Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
מצבים רפואיים
Metastatic Uveal Melanoma · Cutaneous Melanoma · Colorectal Cancer · Other Solid Tumors
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
UCLA Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Bartosz Chmielowski, MD)San Francisco Oncology Associates, San Francisco, California, United States
SCRI - Denver, Denver, Colorado, United States
Contact: Principal Investigator (Ryan Weight, MD)University of Iowa, Iowa City, Iowa, United States
Cancer Hematology Centers Western Michigan, Grand Rapids, Michigan, United States
Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (April Salama, MD)University of Cincinnati Cancer Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Trisha Wise-Draper, MD)The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Marlana Orloff, MD)The Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, United States
Contact: Principal Investigator (Meredith McKean, MD)The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jordi Rodon Ahnert, MD)Westmead Hospital, Sydney, New South Wales, Australia
Queensland, Woolloongabba, Australia
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
מובילי המחקר
George Cole Jr., MD
Study Director
gcole@ideayabio.com